Literature DB >> 14670319

Impact of routine vaccination with a conjugate Haemophilus influenzae type b vaccine.

Anders Hviid1, Mads Melbye.   

Abstract

Based on a unique nationwide registration of vaccinated children, we studied the impact of routine Hib vaccination with special emphasis on vaccine uptake and adherence, vaccine effectiveness with respect to Hib meningitis, and indirect effects with respect to Hib meningitis among the unvaccinated children. Uptake and adherence was generally satisfactory. We estimated >97% effectiveness for all three doses of vaccine and observed herd-immunity in unvaccinated children comparable to a vaccine effectiveness of 94% 3.5 years into the programme. In conclusion, nationwide routine Hib vaccination is highly effective in protecting against Hib meningitis, and rapid achievement of herd immunity is possible with catch-up vaccination of older children.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14670319     DOI: 10.1016/j.vaccine.2003.08.001

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Serological protection induced by Haemophilus influenzae Type B conjugate vaccine in Mexican children: is a booster dose of the vaccine needed?

Authors:  Romeo S Rodriguez; Cesar Mascarenas; Carlos J Conde-Glez; Jaime Inostroza; Sonia Villanueva; María Elena Velázquez; Miguel Angel Sánchez-Alemán; Gabriela Echániz
Journal:  Clin Vaccine Immunol       Date:  2010-08-18

2.  National analysis of bacterial meningitis in Slovakia, 1997-2007.

Authors:  Henrieta Hudeckova; Milos Jesenak; Avdicova Maria; Viera Svihrova; Peter Banovcin
Journal:  Public Health Rep       Date:  2010 Jan-Feb       Impact factor: 2.792

Review 3.  Valuing vaccination.

Authors:  Till Bärnighausen; David E Bloom; Elizabeth T Cafiero-Fonseca; Jennifer Carroll O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

4.  Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001-2003.

Authors:  David Scheifele; Scott Halperin; Barbara Law; Arlene King; Scott Halperin; Robert Morris; Charles A Janeway; Pierre Déry; Marc Lebel; Dorothy Moore; Nicole Le Saux; Elizabeth Ford-Jones; Ben Tan; Taj Jadavji; Wendy Vaudry; Wikke Walop; Joanne Embree; John Waters
Journal:  CMAJ       Date:  2005-01-04       Impact factor: 8.262

5.  Poor clinical outcome for meningitis caused by Haemophilus influenzae serotype A strains containing the IS1016-bexA deletion.

Authors:  Josilene B T Lima; Guilherme S Ribeiro; Soraia M Cordeiro; Edilane L Gouveia; Kátia Salgado; Brian G Spratt; Daniel Godoy; Mitermayer G Reis; Albert I Ko; Joice N Reis
Journal:  J Infect Dis       Date:  2010-10-08       Impact factor: 5.226

6.  Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.

Authors:  Dominic F Kelly; E Richard Moxon; Ly-Mee Yu; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2008-09-10

Review 7.  Bacterial meningitis: the impact of vaccination.

Authors:  Nick Makwana; F Andrew I Riordan
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Eight-plex PCR and liquid-array detection of bacterial and viral pathogens in cerebrospinal fluid from patients with suspected meningitis.

Authors:  Mette Kusk Bøving; Lisbeth Nørum Pedersen; Jens Kjølseth Møller
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

9.  Progress in vaccination against Haemophilus influenzae type b in the Americas.

Authors:  M Carolina Danovaro-Holliday; Salvador Garcia; Ciro de Quadros; Gina Tambini; Jon K Andrus
Journal:  PLoS Med       Date:  2008-04-22       Impact factor: 11.069

10.  Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period.

Authors:  Maria N Theodoridou; Vasiliki A Vasilopoulou; Erato E Atsali; Anastasia M Pangalis; Glyceria J Mostrou; Vassiliki P Syriopoulou; Christos S Hadjichristodoulou
Journal:  BMC Infect Dis       Date:  2007-08-30       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.